EMPIRE: a randomized, placebo-controlled study assessing Efficacy, safety and dose response of vatelizumab in Patients with Relapsing-remitting MSE. Havrdova, A. Bar-Or, H. -P. Hartung,S. Schippling, C. Tonatore, S. N. Rakhade,I. A. Antonijevic,L. Ross, L. Martell,M. A. PanzaraMULTIPLE SCLEROSIS JOURNAL（2015）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
